Related Experiment Video
Updated: Apr 9, 2026

A Novel Surgical Technique in a Sheep Model for Suburethral Graft Implantation
Published on: June 20, 2025
New treatments for incontinence.
Lara S MacLachlan1, Eric S Rovner1
1Department of Urology, Lahey Hospital and Medical Center, Burlington, MA; Department of Urology, Medical University of South Carolina, Charleston, SC.
Urinary incontinence (UI) affects quality of life and has medical risks. This review covers current and emerging treatments for stress, urge, mixed, and overflow UI in adults.
Area of Science:
- Urology
- Geriatrics
- Women's Health
Background:
- Urinary incontinence (UI) is a prevalent condition impacting patient quality of life.
- Untreated UI can lead to serious medical issues like infections, falls, and skin breakdown.
- Understanding UI pathophysiology is crucial for effective management.
Purpose of the Study:
- To review current therapeutic strategies for various types of adult urinary incontinence.
- To explore novel and emerging treatments for stress, urge, mixed, and overflow UI.
- To provide a comprehensive overview of UI management for healthcare professionals.
Main Methods:
- Literature review of existing and emerging treatments for urinary incontinence.
- Categorization of UI based on underlying pathophysiology: stress, urge, mixed, and overflow.
- Analysis of treatment goals including reducing episodes, preventing complications, and restoring continence.
Main Results:
- Current treatments aim to reduce UI episodes and prevent complications.
- Various therapeutic options exist for stress, urge, mixed, and overflow incontinence.
- Novel and future therapies are being developed to improve UI management.
Conclusions:
- Effective management of urinary incontinence requires addressing its specific type and underlying causes.
- A range of treatments, from established to novel, are available for adult UI.
- Continued research into emerging therapies promises improved outcomes for incontinence patients.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Urinary Tract Infection IV: Nursing Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Drugs for Treatment of Constipation-Predominant IBS
Urinary Tract Calculi III: Medical Management
